Monika Fischer, MD, reviewing Sazonovs A, et al. Gastroenterology 2020 Jan. In this genome-wide association study, 1240 patients with biologic-naive Crohn’s disease were treated with
biomarker
biomarker
Crohn’s Disease Patients with HLA-DQA1*05 Allele at Increased Risk of Antidrug Antibody Development
Crohn’s Disease Patients with HLA-DQA1*05 Allele at Increased Risk of Antidrug Antibody Development
